XOMA Corp (NASDAQ:XOMA)
| 17.87 Delayed Data As of Sep 28 |  +0.72 / +4.20%Today’s Change | 15.68 Today|||52-Week Range 32.09 | -14.29% Year-to-Date |
Latest XOMA News | Press Releases
No recent news for XOMA Corp.
Today’s Trading
| Previous close | 17.15 |
| Today’s open | 17.11 |
| Day’s range | 17.11 - 17.87 |
| Volume | 178 |
| Average volume (3 months) | 49,258 |
| Market cap | $186.9M |
Data as of 4:00pm ET, 09/28/2022
Growth & Valuation
| Earnings growth (last year) | -16.27% |
| Earnings growth (this year) | -208.72% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | +29.86% |
| P/E ratio | 21.8 |
| Price/Sales | 6.66 |
| Price/Book | 1.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RIGLRigel Pharmaceutical... | +0.07 | +6.09% |
| KMDAKamada Ltd | +0.04 | +0.90% |
| AUTLAutolus Therapeutics... | +0.14 | +6.57% |
| LCTXLineage Cell Therape... | +0.05 | +4.39% |
Data as of 4:00pm ET, 09/28/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $38.2M |
| Annual profit (last year) | $12.3M |
| Net profit margin | 32.36% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
